Social Media Fundraising Resources

Copy and paste the below to Facebook, X (formerly Twitter), Instagram, and/or LinkedIn (or whichever social media platform you choose). Remember to include the link to your Jimmy Fund Walk fundraising page with each post!

• Every step we take against cancer at the Jimmy Fund Walk makes a difference for patients at Dana-Farber—and around the world. Will you support my walk? #JimmyFundWalk
• I’m taking steps to defy cancer at the Jimmy Fund Walk. Every donation to my walk will make an impact on the lives of patients and families at Dana-Farber. #JimmyFundWalk
• Together, our impact adds up. Donate to my walk and help fuel groundbreaking cancer research and compassionate patient care at Dana-Farber. Every dollar helps! #JimmyFundWalk
• We walk together against cancer. Join my team in the Jimmy Fund Walk to benefit cancer research and care at Dana-Farber. #JimmyFundWalk

Starting a Facebook Fundraiser is an easy and effective way to help you reach your fundraising goal. On average, walkers who create Facebook Fundraisers raise 86% more than those who do not. Please note: You must create your Facebook Fundraiser through your Participant Center for the funds to flow directly to your Walk fundraising page. If prompted, do not sync your Facebook Fundraiser to Instagram. Gifts received through Instagram will not flow over to your fundraising page and count towards your total.

1. Log in to your Participant Center and select “Start Fundraiser” from your Next Steps.
2. Log in to your Facebook account through the pop-up window on-screen.
3. On the next pop-up window, allow the Jimmy Fund to receive your name, profile photo, and manage your Facebook Fundraiser by clicking the “Continue as [Your Name]” button.
4. The pop-up will close, and the link to access your Facebook Fundraiser will appear in your Participant Center’s Next Steps section.
5. Personalize your Facebook Fundraiser through your Facebook account with a photo and the reasons you are raising funds. Your Fundraiser will automatically post to your News Feed to spread the word to your family and friends!

Learn more about Facebook Fundraisers here.

Share any of the below facts in your social media posts about what sets Dana-Farber and the Jimmy Fund apart to inspire friends and family to support your walk and understand why it’s important to support cancer research and care at Dana-Farber specifically.

About Dana-Farber

• Dana-Farber is one of the world’s leading centers of cancer research and treatment. Dedicated to a unique and equal balance between cancer research and care, Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy. Supporting Dana-Farber benefits patients in Boston—and everywhere.
• Dana-Farber Cancer Institute has been the top-ranked cancer hospital in New England by U.S. News & World Report for 23 consecutive years, and is the only cancer center in the country ranked in the top 5 for both adult and pediatric cancer programs.
• Dana-Farber’s founder, Dr. Sidney Farber, achieved the first-ever remissions of childhood leukemia.
• Dana-Farber was recognized by the Human Rights Campaign’s 2022 Healthcare Equality Index with its top ranking, “LGBTQ Health Care Equality Leader,” receiving the highest possible score of 100%.

Dana-Farber's Impact

• In 1980, there were fewer than 5 million cancer survivors in the United States. Today, with help from the Jimmy Fund Walk, there are more than 18 million.
• Dana-Farber helped raise the recovery rate to as high as 90% in some forms of childhood cancer. We walk so that one day, it is 100%.
• In 1975, the 5-year survival rate for breast cancer was 75%. Today, it is over 90%. We walk so that one day, it is 100%.
• Dana-Farber offers more than 1,100 clinical trials. That’s 1,100 opportunities to discover a breakthrough—all made possible with help from generous Jimmy Fund supporters.
• Dana-Farber investigators played a substantial role in the development of over half of all cancer drugs approved by the FDA in the last five years, including accelerated approval for a novel treatment for metastatic HR-positive, HER2-negative breast cancer in 2023.